The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity
Abstract
PURPOSE OF REVIEW: To highlight the potential importance of advanced glycation endproducts (AGEs) and advanced-lipoxidation endproducts (ALEs) in obesity and obesity-related complications, and the contribution of the receptor for advanced glycation endproducts (RAGE) and the glyoxylase defense system therein. RECENT FINDINGS: Formation of AGEs/ALEs and its precursors, including methylglyoxal (MGO), are increased in conditions characterized by hyperglycemia, hyperlipidemia and enhanced oxidative stress. This metabolic profile is generally considered typical for obesity. Increased plasma and/or tissue levels of MGO and of specific AGEs/ALEs, such as N(ε)-(carboxymethyl)lysine (CML), in obesity have recently been described. In addition to increased formation, the suppressed defense system in obesity against AGEs/ALEs formation, that is, the glyoxylase system, will further contribute to AGEs/ALEs formation in obesity. AGEs/ALEs are not inert. In-vitro studies showed that AGEs induced the production of inflammatory mediators in adipocytes and macrophages via RAGE activation, which may subsequently contribute to the development of obesity-related complications. SUMMARY: The recognition of an enhanced AGEs/ALEs formation in adipose tissue and the biological consequences thereof may lead to a further understanding of underlying mechanisms in dysregulated production of adipokines in obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The formation of AGEs (the Maillard reaction) starts with the reaction of sugar aldehydes with the N-terminus of free-amino groups of proteins to form a so-called Schiff base [187].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [187]
In the citing paper
“The studies derived from these techniques evidence a net increased AGEs level in obesity [187], Diabetes Mellitus [207] and chronic inflammatory diseases, like Rheumatoid Arthritis [208], as well as in age-related diseases, such as cardiovascular, renal and neurodegenerative pathologies [193,209].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [187]
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“Unau 0957-9672 2013 Wolters Kluwer Health | Lippincott Williams & Wilk obesity-related inflammation and development of insulin resistance and type 2 diabetes in obesity [1,2].”
BackgroundBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597 · cited 2×
“Therefore, accelerated AGEs/ALEs formation is seen in diabetes, but also in age-related diseases, such as atherosclerosis and neurodegenerative disorders including Alzheimer’s disease [3,7].”
BackgroundAdipose tissue as an endocrine organ
Galic, S., Oakhill, J. S., & Steinberg, G. R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.018 · Cited by 1,562 · cited 2×
“Unau 0957-9672 2013 Wolters Kluwer Health | Lippincott Williams & Wilk obesity-related inflammation and development of insulin resistance and type 2 diabetes in obesity [1,2].”
BackgroundUnderstanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297 · cited 2×
“AGEs have been found to significantly reduce GLO1 expression and activity in cultured fibroblasts, endothelial cells and neuronal cells, whereas inhibition of RAGE restores GLO1 in these cells [21,22].”
BackgroundFormation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
Thornalley, P. J., LANGBORG, A., & Minhas, H. S. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440109 · Cited by 1,243 · cited 1×
“resulting in a very fast formation of specific AGEs within hours [9].”
BackgroundKislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Du Yan, S., Hofmann, M., Yan, S. F., Pischetsrieder, M., Stern, D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 869 · cited 1×
“As CML is a major ALE, and is an important ligand for RAGE that can activate RAGE-dependent signaling pathways [25], CML may be regarded as an important protein modification in obesity with significant effects on adipose tissue and adipocyte function.”
BackgroundFu, M.-X., Requena, J. R., Jenkins, A. J., Lyons, T. J., Baynes, J. W., & Thorpe, S. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9982 · Cited by 822 · cited 4×
“Modification of proteins originating from lipid peroxidation reactions produces characteristic ALEs, such as MDA-lysine and HNE-lysine, but also CML and CEL [8].”
BackgroundInfluentialNonenzymatic Browning in Vivo: Possible Process for Aging of Long-Lived Proteins
Monnier, V. M., & Cerami, A. (1981) · Science · doi:10.1126/science.6779377 · Cited by 764 · cited 2×
“believed that AGEs accumulate only on long-lived extracellular proteins [6].”
Background
Research works printed but not linked: 1
- Song, 2007, RAGE regulates obesity and hyperglycmia induced by high-fat feeding in mice., Diabetes, 56, A451
Cited by
Manna, P., & Jain, S. K. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0095 · Cited by 1,145
“Ox-LDL-induced alteration in adipokine secretion can also induce CVD complications.(138) Higher OxLDL in obese subjects may be due to lower serum activity of antioxidant enzymes(139) or reduced PON-1 levels.”
BackgroundOxidative stress in obesity: A critical component in human diseases
Marseglia, L., Manti, S., D’Angelo, G., Nicotera, A., Parisi, E., Di Rosa, G., Gitto, E., & Arrigo, T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010378 · Cited by 933
“For example, Ox-LDL decreases the release of adiponectin, which inhibits ROS synthesis [101].”
BackgroundScheijen, J. L. J. M., Clevers, E., Engelen, L., Dagnelie, P. C., Brouns, F., Stehouwer, C. D. A., & Schalkwijk, C. G. (2016) · Food Chemistry · doi:10.1016/j.foodchem.2015.06.049 · Cited by 343
Self-citationShen, C.-Y., Lu, C.-H., Wu, C.-H., Li, K.-J., Kuo, Y.-M., Hsieh, S.-C., & Yu, C.-L. (2020) · Molecules · doi:10.3390/molecules25235591 · Cited by 301
“[47] reported that increased plasma and tissue levels of MGO, AGEs, and advanced lipoxidation end products (ALE) surrogated by CML were found in obesity.”
BackgroundThe Pathogenesis of Obesity-Associated Adipose Tissue Inflammation
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_9 · Cited by 287
Metadata
- Authors
- Gaens, K. H., Stehouwer, C. D., & Schalkwijk, C. G.
- Affiliations
- Maastricht University Medical Centre (NL)
- Corresponding author
- Schalkwijk, Casper G.
- Venue
- Current Opinion in Lipidology
- Published
- 2013-02
- Volume
- 24
- Issue
- 1
- Pages
- 4-11
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2048970664
- Cited by
- 166
- References
- 64
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 11 · 2023: 10 · 2022: 13 · 2021: 13 · 2020: 9 · 2019: 14 · 2018: 10 · 2017: 16 · 2016: 12 · 2015: 19 · 2014: 17 · 2013: 5
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- Nierstichting
- Center for Translational Molecular Medicine
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Keywords
- advanced glycation end products, receptor for advanced glycation end products, obesity, methylglyoxal, oxidative stress, hyperglycemia, hyperlipidemia, adipose tissue, inflammation, adipokines, obesity complications
- MeSH terms
- Receptor for Advanced Glycation End Products, Adipose Tissue, Humans, Hyperlipidemias, Lactoylglutathione Lyase, Macrophages, Obesity, Pyruvaldehyde, Receptors, Immunologic, Lipid Peroxidation, Signal Transduction, Glycation End Products, Advanced, Adipocytes, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. https://app.cochat.ai/papers/10.1097/mol.0b013e32835aea13
- The paper
- Gaens, K. H., Stehouwer, C. D., & Schalkwijk, C. G. (2013). Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. Current Opinion in Lipidology. https://doi.org/10.1097/mol.0b013e32835aea13
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.